Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol vs sufentanil on early postoperative cognitive function and inflammation in elderly patients
ChiCTR2300070805Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Dalian Medical University
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol in post-operative cognitive decline (POCD) (2 arms), sponsored by The First Affiliated Hospital of Dalian Medical University. Primary endpoint: Incidence of postoperative cognitive dysfunction. Planned start Apr 2023; status: not yet recruiting.
02
Drugs
butorphanol
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2300070805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070805.